fashion -WSS

fashion

author：Wikipedia 2025-09-27 09:54:22 - browse：89

Adam's take main illustration — Molly Ferguson/STAT

This week, I address pushback I received on my Novartis-MorphoSys column. But first, a preview of the expected readout from Gritstone Bio’s neoantigen cancer vaccine study.

A looming test for neoantigen cancer vaccines

Before the end of the quarter, Gritstone Bio will release preliminary results from a randomized, Phase 2 clinical trial investigating a personalized therapeutic cancer vaccine in microsatellite-stable colon cancer, a type of “immunologically cold” tumor that is resistant to immunotherapies like PD-1/PD-L1 inhibitors.

The Gritstone vaccine is designed to train a patient’s own T cells to recognize and kill cancer cells by targeting mutated cancer proteins, called neoantigens, that are unique to a patient’s own tumor. It’s a relatively new approach for cancer vaccines — made possible by powerful and relatively inexpensive genomic sequencing of tumors – that is intended to overcome all the previous failures in the field. Gritstone’s effort is also similar to one being used by Moderna and Merck that has reported encouraging results in melanoma — and is now being investigated in a Phase 3 study.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： After affirmative action ruling, medical educators look to 'holistic review'
Next article： Beware reading your test results before your doctor does

explore

WSS

Vertex cell therapy lets patients with type 1 diabetes stop insulin

FDA gives detailed accounting of AI

FDA warns J&J's Abiomed: We will regulate your software

How climate

Undocumented workers face uncertainty as immigration law takes effect in Florida

Researchers explore possible ties between long Covid, menopause

leisure time

fashion

A looming test for neoantigen cancer vaccines

Wikipedia

Bright Health sells Medicare Advantage business to Molina

The wait for US passports is creating travel purgatory and snarling summer plans

Medical records are filled with copy

Canadians with cystic fibrosis outlive Americans by a decade

At least 13 dead in Texas as scorching temps continue

CEOs share strategies for surviving biotech slump

Medicare details structure of new drug price negotiation program

Prescription digital therapeutics are key to pharma’s future

Bright Health sells Medicare Advantage business to Molina

STAT Summit: Michael J. Fox on progress in Parkinson's research

Wikipedia

Skip the lead apron during X

Use doctors trained outside the U.S. to ease the physician shortage

STAT Readout Newsletter: Today's biggest biotech updates

Canadians with cystic fibrosis outlive Americans by a decade

STAT Readout Newsletter: Today's biggest biotech updates

STAT Readout Newsletter: Today's biggest biotech updates

explore

explore

focus

entertainment